JP2021519612A5 - - Google Patents
Info
- Publication number
- JP2021519612A5 JP2021519612A5 JP2021502719A JP2021502719A JP2021519612A5 JP 2021519612 A5 JP2021519612 A5 JP 2021519612A5 JP 2021502719 A JP2021502719 A JP 2021502719A JP 2021502719 A JP2021502719 A JP 2021502719A JP 2021519612 A5 JP2021519612 A5 JP 2021519612A5
- Authority
- JP
- Japan
- Prior art keywords
- aav6
- modified
- raav6
- vector
- neutralization
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862649691P | 2018-03-29 | 2018-03-29 | |
| US62/649,691 | 2018-03-29 | ||
| PCT/US2019/024567 WO2019191418A1 (en) | 2018-03-29 | 2019-03-28 | Liver tropic recombinant aav6 vectors that evade neutralization |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021519612A JP2021519612A (ja) | 2021-08-12 |
| JPWO2019191418A5 JPWO2019191418A5 (https=) | 2022-01-26 |
| JP2021519612A5 true JP2021519612A5 (https=) | 2022-01-26 |
Family
ID=68060427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021502719A Pending JP2021519612A (ja) | 2018-03-29 | 2019-03-28 | 中和を回避する肝臓向性組換えａａｖ６ベクター |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210032660A1 (https=) |
| EP (1) | EP3781187A4 (https=) |
| JP (1) | JP2021519612A (https=) |
| CN (1) | CN112218880A (https=) |
| CA (1) | CA3095127A1 (https=) |
| WO (1) | WO2019191418A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210017542A1 (en) * | 2018-03-29 | 2021-01-21 | University Of Florida Research Foundation, Incorporated | Aav6 variants |
| CN117801116A (zh) * | 2022-09-30 | 2024-04-02 | 上海玮美基因科技有限责任公司 | 一种融合型新型腺相关病毒及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006110689A2 (en) * | 2005-04-07 | 2006-10-19 | The Trustees Of The University Of Pennsylvania | Method of increasing the function of an aav vector |
| US9533189B2 (en) * | 2012-05-30 | 2017-01-03 | Jaime Cameron | Push-up exercise apparatus |
| KR102234672B1 (ko) * | 2013-05-21 | 2021-04-06 | 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 | 캡시드-변형된 raav3 벡터 조성물, 및 인간 간암의 유전자 요법에서의 용도 |
| GB201403684D0 (en) * | 2014-03-03 | 2014-04-16 | King S College London | Vector |
| JP2017048681A (ja) * | 2015-08-31 | 2017-03-09 | 株式会社マーレ フィルターシステムズ | ポンプ |
| BR112018003665A2 (en) * | 2015-09-28 | 2018-09-25 | The University Of North Carolina At Chapel Hill | methods and compositions for antibody evasion viral vectors |
| EP4659816A3 (en) * | 2015-12-14 | 2025-12-31 | The University of North Carolina at Chapel Hill | MODIFIED CAPSID PROTEINS FOR IMPROVED PARVOVIRUS VECTOR DELIVERY |
-
2019
- 2019-03-28 US US17/042,543 patent/US20210032660A1/en not_active Abandoned
- 2019-03-28 EP EP19776047.3A patent/EP3781187A4/en not_active Withdrawn
- 2019-03-28 CA CA3095127A patent/CA3095127A1/en active Pending
- 2019-03-28 WO PCT/US2019/024567 patent/WO2019191418A1/en not_active Ceased
- 2019-03-28 JP JP2021502719A patent/JP2021519612A/ja active Pending
- 2019-03-28 CN CN201980035877.5A patent/CN112218880A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Paulk et al. | Bioengineered AAV capsids with combined high human liver transduction in vivo and unique humoral seroreactivity | |
| Sonntag et al. | The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes | |
| US12534717B2 (en) | AAV capsid proteins for nucleic acid transfer | |
| Lisowski et al. | Selection and evaluation of clinically relevant AAV variants in a xenograft liver model | |
| JP7438981B2 (ja) | アデノ随伴ウイルスの肝臓特異的向性 | |
| Gaggar et al. | CD46 is a cellular receptor for group B adenoviruses | |
| JP6947739B2 (ja) | 既存のヒト中和抗体に対して耐性である新規組換えアデノ随伴ウイルスカプシド | |
| US10214566B2 (en) | Mutant adeno-associated virus virions and methods of use thereof | |
| Gall et al. | Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype | |
| US10046016B2 (en) | Mutant adeno-associated virus virions and methods of use thereof | |
| Bello et al. | Novel adeno-associated viruses derived from pig tissues transduce most major organs in mice | |
| Wen et al. | A novel porcine circovirus-like agent P1 is associated with wasting syndromes in pigs | |
| Qiu et al. | Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions | |
| Qian et al. | Directed evolution of AAV serotype 5 for increased hepatocyte transduction and retained low humoral seroreactivity | |
| Michelfelder et al. | Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo | |
| Bennett et al. | AAV6 K531 serves a dual function in selective receptor and antibody ADK6 recognition | |
| Kariatsumari et al. | Construction and nucleotide sequence analysis of an infectious DNA clone of the autonomous parvovirus, mink enteritis virus | |
| Tomita et al. | Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administration | |
| JP2021519612A5 (https=) | ||
| JP2021528639A (ja) | Ａａｖ治療の方法 | |
| Li et al. | Pre-existing antibodies to candidate gene therapy vectors (adeno-associated vector serotypes) in domestic cats | |
| Löser et al. | Ovine adenovirus vectors mediate efficient gene transfer to skeletal muscle | |
| Lin et al. | Construction and immunogenicity of a recombinant swinepox virus expressing a multi-epitope peptide for porcine reproductive and respiratory syndrome virus | |
| CN114450032A (zh) | 病毒载体生产的效价测定 | |
| Rasmussen et al. | Efficient generation of recombinant RNA viruses using targeted recombination-mediated mutagenesis of bacterial artificial chromosomes containing full-length cDNA |